glp-1 news oct 9 2025 trends 2025: real-world data, patient outcomes & future therapies Understanding GLP-1s and their dynamic
Description
No LLM hallucinations
Rybelsus is taken orally once daily
The FDA signaled new limits on non-approved compounded GLP-1 APIs being mass-marketed, and it explicitly called out Hims
doi: 10.7759/cureus.32630 [DOI] [PMC free article] [PubMed] [Google Scholar] 24.Emous M, Wolffenbuttel BHR, van Dijk G, Tott E, van Beek AP
If national cultures change how they value innovation or equity, NICE and ICER will reflect that
